Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma

Clinical trial NCT00193505 · COMPLETED

Trial details

NCT number: NCT00193505
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkins Lymphoma

Start date: 2003-10-01
Primary completion: 2005-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.